157 related articles for article (PubMed ID: 7494822)
1. Mechanisms of transport of quinapril in Caco-2 cell monolayers: comparison with cephalexin.
Hu M; Zheng L; Chen J; Liu L; Zhu Y; Dantzig AH; Stratford RE
Pharm Res; 1995 Aug; 12(8):1120-5. PubMed ID: 7494822
[TBL] [Abstract][Full Text] [Related]
2. Uptake characteristics of loracarbef and cephalexin in the Caco-2 cell culture model: effects of the proton gradient and possible presence of a distinctive second component.
Hu M; Chen J; Zheng L; Dantzig AH; Stratford RE
J Pharm Sci; 1996 Jul; 85(7):767-72. PubMed ID: 8819004
[TBL] [Abstract][Full Text] [Related]
3. Metabolism, uptake, and transepithelial transport of the stereoisomers of Val-Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Nov; 13(11):1663-7. PubMed ID: 8956331
[TBL] [Abstract][Full Text] [Related]
4. Cefaclor uptake by the proton-dependent dipeptide transport carrier of human intestinal Caco-2 cells and comparison to cephalexin uptake.
Dantzig AH; Tabas LB; Bergin L
Biochim Biophys Acta; 1992 Dec; 1112(2):167-73. PubMed ID: 1457450
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of angiotensin-converting enzyme inhibitor on cefroxadine uptake by rabbit small intestinal brush border membrane vesicles.
Kitagawa S; Takeda J; Kaseda Y; Sato S
Biol Pharm Bull; 1997 Apr; 20(4):449-51. PubMed ID: 9145229
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the pharmacokinetic interaction between cephalexin and quinapril by a nonlinear mixed-effect model.
Padoin C; Tod M; Perret G; Petitjean O
Antimicrob Agents Chemother; 1998 Jun; 42(6):1463-9. PubMed ID: 9624495
[TBL] [Abstract][Full Text] [Related]
7. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
8. Metabolism, uptake, and transepithelial transport of the diastereomers of Val-Val in the human intestinal cell line, Caco-2.
Tamura K; Bhatnagar PK; Takata JS; Lee CP; Smith PL; Borchardt RT
Pharm Res; 1996 Aug; 13(8):1213-8. PubMed ID: 8865315
[TBL] [Abstract][Full Text] [Related]
9. Mechanism and kinetics of transcellular transport of a new beta-lactam antibiotic loracarbef across an intestinal epithelial membrane model system (Caco-2).
Hu M; Chen J; Zhu Y; Dantzig AH; Stratford RE; Kuhfeld MT
Pharm Res; 1994 Oct; 11(10):1405-13. PubMed ID: 7855043
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
Thwaites DT; Cavet M; Hirst BH; Simmons NL
Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of carbacephalosporins and cephalosporins: antibacterial activity and interaction with the intestinal proton-dependent dipeptide transport carrier of Caco-2 cells.
Snyder NJ; Tabas LB; Berry DM; Duckworth DC; Spry DO; Dantzig AH
Antimicrob Agents Chemother; 1997 Aug; 41(8):1649-57. PubMed ID: 9257735
[TBL] [Abstract][Full Text] [Related]
12. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
[TBL] [Abstract][Full Text] [Related]
13. Function and immunolocalization of overexpressed human intestinal H+/peptide cotransporter in adenovirus-transduced Caco-2 cells.
Hsu CP; Walter E; Merkle HP; Rothen-Rutishauser B; Wunderli-Allenspach H; Hilfinger JM; Amidon GL
AAPS PharmSci; 1999; 1(3):E12. PubMed ID: 11741208
[TBL] [Abstract][Full Text] [Related]
14. Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.
Sun BW; Zhao XC; Wang GJ; Li N; Li JS
World J Gastroenterol; 2003 Apr; 9(4):808-12. PubMed ID: 12679938
[TBL] [Abstract][Full Text] [Related]
15. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
Dantzig AH; Duckworth DC; Tabas LB
Biochim Biophys Acta; 1994 Apr; 1191(1):7-13. PubMed ID: 8155686
[TBL] [Abstract][Full Text] [Related]
16. Competitive inhibition of glycylsarcosine transport by enalapril in rabbit renal brush border membrane vesicles: interaction of ACE inhibitors with high-affinity H+/peptide symporter.
Lin CJ; Akarawut W; Smith DE
Pharm Res; 1999 May; 16(5):609-15. PubMed ID: 10350000
[TBL] [Abstract][Full Text] [Related]
17. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2.
Dantzig AH; Bergin L
Biochim Biophys Acta; 1990 Sep; 1027(3):211-7. PubMed ID: 2397233
[TBL] [Abstract][Full Text] [Related]
18. Comparison of bidirectional cephalexin transport across MDCK and caco-2 cell monolayers: interactions with peptide transporters.
Putnam WS; Pan L; Tsutsui K; Takahashi L; Benet LZ
Pharm Res; 2002 Jan; 19(1):27-33. PubMed ID: 11837697
[TBL] [Abstract][Full Text] [Related]
19. Effects of progesterone and norethisterone on cephalexin transport and peptide transporter PEPT1 expression in human intestinal cell line Caco-2.
Watanabe K; Jinriki T; Sato J
Biol Pharm Bull; 2006 Jan; 29(1):90-5. PubMed ID: 16394517
[TBL] [Abstract][Full Text] [Related]
20. Stoichiometry and kinetics of the high-affinity H+-coupled peptide transporter PepT2.
Chen XZ; Zhu T; Smith DE; Hediger MA
J Biol Chem; 1999 Jan; 274(5):2773-9. PubMed ID: 9915809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
